AbbVie and Richter partner for neuropsychiatric treatments

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Oct 26, 2024 - 04:00

AbbVie and Richter partner for neuropsychiatric treatments

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Read the original article

Tags:

Previous Article

Takeda and BMC partner to decarbonise US healthcare sector

US CDC AdCom recommends lowering the age for pneumococcal vaccines

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

BGB-10188 by BeiGene for Epithelial Ovarian Cancer: Lik...

Oct 29, 2023

Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval

Bavarian Nordic wins positive CHMP opinion to amend Imv...

Jul 28, 2024

Reality Bites: Disappointment in the R&D Sector

Reality Bites: Disappointment in the R&D Sector

Apr 16, 2023